Thursday, November 20, 2008

London Business School Global Healthcare Conference, December 1, 2008

(Press Release)

The London Business School Healthcare Club is delighted to announce the first London Business School Global Healthcare Conference, to be held on December 1st, 2008 at the Royal College of Obstetricians and Gynaecologists, Regents Park, London. Conference organizers expect 250 delegates.

The purpose of the conference is to provide a forum for healthcare leaders, London Business School alumni and current students to openly discuss issues facing the healthcare sector. Conference delegates will explore the global healthcare industry, led by prestigious speakers who will share insights on current and future industry opportunities and challenges.

Panels will engage in thought-provoking debate on issues faced by pharmaceutical, biotechnology and medical technology firms with a focus on the emerging markets. In addition to educating delegates, fostering an exchange of ideas and providing an opportunity to network, the conference will increase student awareness regarding the most exciting employers in this sector.

The conference will have a keynote address and two plenary sessions. The keynote address, "Perspectives on the Future of Healthcare" will be delivered by William Burns, CEO of Roche Pharma

The first plenary session is on "Financing and Access of Healthcare in the Emerging Markets". Confirmed panellists include; Jon Symonds - Managing Partner Goldman Sachs and Ex CFO Astrazeneca, Nicolaus Henke - Lead Healthcare Partner McKinsey London Office and David Redfern - Head of Strategy GlaxoSmithKline

The second plenary session "New Ventures and Technology in Healthcare" will feature the following speakers; Alan Mackay - Partner and Head of Healthcare 3i, Prof Simon Best - Entrepreneur in Residence and Partner TVM Capital and Dr John Patterson - Head of R&D Astrazeneca

For further information please visit or email

Addendum: The London Business School Global Healthcare Conference shares a significant number of speakers with the Financial Times, FT Global Pharmaceutical and Biotechnology Conference. The FT conference registration costs € 1,500, whereas the London Business School conference is about 1/100th of that cost and is open to the public – that means you!

No comments: